Associated Papers
CDK4 overexpression is a predictive biomarker for resistance to conventional chemotherapy in patients with osteosarcoma.
Iwata S et al.
Oncology Reports, 2021
34036394 (PubMed )
Supplement: supplement_1.pdf
Select a paper to view details